Effect of Dangua Humai Oral Liquid on Vascular Endothelial Function and Oxidative Stress Indicators in Patients with Type 2 Diabetes Mellitus Complicated with Non-Alcoholic Fatty Liver Disease
返回论文页
|更新时间:2022-10-08
|
Effect of Dangua Humai Oral Liquid on Vascular Endothelial Function and Oxidative Stress Indicators in Patients with Type 2 Diabetes Mellitus Complicated with Non-Alcoholic Fatty Liver Disease
CHEN Minling, WANG Zhita, YANG Liuqing, et al. Effect of Dangua Humai Oral Liquid on Vascular Endothelial Function and Oxidative Stress Indicators in Patients with Type 2 Diabetes Mellitus Complicated with Non-Alcoholic Fatty Liver Disease. [J]. 21(8):918-921(2021)
DOI:
CHEN Minling, WANG Zhita, YANG Liuqing, et al. Effect of Dangua Humai Oral Liquid on Vascular Endothelial Function and Oxidative Stress Indicators in Patients with Type 2 Diabetes Mellitus Complicated with Non-Alcoholic Fatty Liver Disease. [J]. 21(8):918-921(2021) DOI: 10.14009/j.issn.1672-2124.2021.08.005.
Effect of Dangua Humai Oral Liquid on Vascular Endothelial Function and Oxidative Stress Indicators in Patients with Type 2 Diabetes Mellitus Complicated with Non-Alcoholic Fatty Liver Disease
治疗前后血糖[空腹血糖(FBG)、餐后2 h血糖(2 h BG)及糖化血红蛋白(Hb Alc)]、血脂[总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白(HDL)及低密度脂蛋白(LDL)]、肝功能[丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)及γ-谷氨酰转移酶(GGT)]、血管内皮功能[血管内皮生长因子(VEGF)、内皮素(ET-1)]及氧化应激[丙二醛(MDA)、超氧化物歧化酶(SOD)]等指标水平。结果:观察组患者的总有效率为89.13%(41/46)
明显高于对照组的71.74%(33/46)
差异有统计学意义(P<0.05)。治疗后
两组患者FBG、2 h BG、Hb Alc、TC、TG、LDL、ALT、AST、GGT、ET-1及MDA水平较治疗前明显降低
OBJECTIVE: To probe into the effect of Dangua Humai oral liquid on vascular endothelial function and oxidative stress indicators in patients with type 2 diabetes mellitus( T2 DM) complicated with non-alcoholic fatty liver disease( NAFLD) under the guidance of co-treatment of phlegm and stasis. METHODS: Totally 92 patients with T2 DM complicated with NAFLD admitted into the Affiliated People ’ s Hospital of Fujian University of Traditional Chinese Medicine from Jan. 2018 to Jul. 2020 were selected and divided into control group( 46 cases) and observation group( 46 cases) according to the admission sequences. The control group was given conventional therapy
while the observation group was given Dangua Humai oral liquid based on the control group under the guidance of co-treatment of phlegm and stasis
both groups were treated for 3 months. The clinical efficacy
blood glucose [fasting blood glucose( FBG)
2 h postprandial blood glucose( 2 hBG) and glycosylated hemoglobin( Hb Alc) ] levels
blood lipid [total cholesterol( TC)
triglyceride( TG)
high-density lipoprotein( HDL) and low-density lipoprotein( LDL) ] levels
liver function indicators [alanine aminotransferase( ALT)
aspartate transaminase( AST) and γ-glutamyltransferase( GGT) ]
vascular endothelial function indicators [vascular endothelial growth factor( VEGF)
superoxide dismutase( SOD) ] levels were compared between two groups before and after treatment. RESULTS: The total effective rate of observation group was 89. 13%( 41/46)
which was significantly higher than that of the control group( 71. 74%
33/46)
with statistically significant difference( P<0. 05). After treatment
the FBG
2 h BG
Hb Alc
TC
TG
LDL
ALT
AST
GGT
ET-1 and MDA levels of both groups had been significantly decreased
while the HDL
VEGF and SOD levels were significantly increased
with statistically significant differences( P < 0. 05); there were no statistical significance in differences in FBG
HbAlc
ALT
AST and GGT levels between observation group and control group( P>0. 05)
the2 hBG
TC
TG
LDL
ET-1 and MDA levels of observation group were significantly lower than those of the control group
while the HDL
VEGF and SOD levels were significantly higher than those of the control group
with statistically significant differences( P < 0. 05). CONCLUSIONS: Under the guidance of co-treatment of phlegm and stasis
Dangua Humai oral liquid can better regulate blood lipid and blood glucose metabolism in patients with T2 DM complicated with NAFLD
improve their vascular endothelial function
reduce oxidative stress and promote therapeutic effect
without significant adverse drug effects.
关键词
2型糖尿病非酒精性脂肪性肝病痰瘀同治丹瓜护脉口服液血管内皮功能氧化应激血糖肝功能
Keywords
Type 2 diabetes mellitusNon-alcoholic fatty liver diseaseCo-treatment of phlegm and stasisDangua Humai oral liquidVascular endothelial functionOxidative stressBlood glucoseLiver function
Effects of Dapagliflozin Combined with Liraglutide on Inflammatory Factors, Glucolipid Metabolism and Liver Function in Patients with Type 2 Diabetes Combined with Non-Alcoholic Fatty Liver Disease
Application Rationality of Antidiabetic Drugs in 100 Inpatients with Type 2 Diabetes Mellitus in One Class Ⅲ Grade A Hospital
Systematic Review of Efficacy and Safety of Semaglutide in the Treatment of Type 2 Diabetes Mellitus
Application of Optimized Treatment 3HLZE/4HR Regimen on Patients with Chronic Viral Hepatitis C Complicated with Tuberculosis
Effects of Reduced Glutathione Infusion on Inflammatory Response in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Related Author
CHU Yang
WANG Deqin
LYU Zhongmei
YU Hengcai
GE Lanlan
NIE Ruifang
ZHANG Chao
ZHANG Yahui
Related Institution
Dept.of Nephroendocrinology, Hai’an Hospital Affiliated to Nantong University
Quality Control and Performance Management Office, Shandong Provincial Hospital Affiliated to Shandong First Medical University
School of Pharmacy, Shandong First Medical University
Dept. of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong First Medical University
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College